Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Arbuthnot

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Advanced Drug Delivery Reviews|June 3, 2020
In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infectionAbdullah Ely, Prashika Singh, Tiffany S Smith, et al.
Genes|April 13, 2018
Gene Therapy for Chronic HBV-Can We Eliminate cccDNA?Kristie Bloom, Mohube Betty Maepa, Abdullah Ely, et al.
Biomed Research International|July 9, 2014
Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV pri-miRs from a liver-specific promoterMohube Betty Mowa, Carol Crowther, Abdullah Ely, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2020
Generating DNA Expression Cassettes Encoding Multimeric Artificial MicroRNA PrecursorsFiona T van den Berg, Abdullah Ely, Patrick Arbuthnot
Microrna (Shariqah, United Arab Emirates)|July 23, 2014
Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAsMohube B Mowa, Carol Crowther, Abdullah Ely, et al.
Expert Opinion on Therapeutic Targets|April 12, 2021
Hepatitis B virus: promising drug targets and therapeutic implicationsMohube Betty Maepa, Kristie Bloom, Abdullah Ely, et al.
Journal of Hepatocellular Carcinoma|February 5, 2021
Recent Update on the Role of Circular RNAs in Hepatocellular CarcinomaAbdullah Ely, Kristie Bloom, Mohube Betty Maepa, et al.
Genes|November 11, 2022
Adenoviral Vectors: Potential as Anti-HBV Vaccines and TherapeuticsTasneem Farhad, Keila Neves, Patrick Arbuthnot, et al.
Pharmaceutics|November 27, 2024
Recent Advances in Designing Adeno-Associated Virus-Based Vaccines Against Viral InfectionsNjabulo Mnyandu, Ridhwaanah Jacobs, Patrick Arbuthnot, et al.
Gene Therapy|November 18, 2024
Bridging gene therapy and next-generation vaccine technologiesKristie Bloom, Abdullah Ely, Mohube Betty Maepa, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Advanced Drug Delivery Reviews|June 3, 2020
In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infectionAbdullah Ely, Prashika Singh, Tiffany S Smith, et al.
Genes|April 13, 2018
Gene Therapy for Chronic HBV-Can We Eliminate cccDNA?Kristie Bloom, Mohube Betty Maepa, Abdullah Ely, et al.
Biomed Research International|July 9, 2014
Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV pri-miRs from a liver-specific promoterMohube Betty Mowa, Carol Crowther, Abdullah Ely, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2020
Generating DNA Expression Cassettes Encoding Multimeric Artificial MicroRNA PrecursorsFiona T van den Berg, Abdullah Ely, Patrick Arbuthnot
Microrna (Shariqah, United Arab Emirates)|July 23, 2014
Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAsMohube B Mowa, Carol Crowther, Abdullah Ely, et al.
Expert Opinion on Therapeutic Targets|April 12, 2021
Hepatitis B virus: promising drug targets and therapeutic implicationsMohube Betty Maepa, Kristie Bloom, Abdullah Ely, et al.
Journal of Hepatocellular Carcinoma|February 5, 2021
Recent Update on the Role of Circular RNAs in Hepatocellular CarcinomaAbdullah Ely, Kristie Bloom, Mohube Betty Maepa, et al.
Genes|November 11, 2022
Adenoviral Vectors: Potential as Anti-HBV Vaccines and TherapeuticsTasneem Farhad, Keila Neves, Patrick Arbuthnot, et al.
Pharmaceutics|November 27, 2024
Recent Advances in Designing Adeno-Associated Virus-Based Vaccines Against Viral InfectionsNjabulo Mnyandu, Ridhwaanah Jacobs, Patrick Arbuthnot, et al.
Gene Therapy|November 18, 2024
Bridging gene therapy and next-generation vaccine technologiesKristie Bloom, Abdullah Ely, Mohube Betty Maepa, et al.
Pageof 11